The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY. Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S.-listed, registered securities electronically during the Regular Trading Hours. Keep in mind that other fees such as regulatory fees, Premium subscription fees, commissions on trades during extended trading hours, wire transfer fees, and paper statement fees may apply to your brokerage account.

HUM earnings call for the period ending June 30, 2021. HUM earnings call for the period ending September 30, 2021. One of these stocks hiked its dividend by as much as 50% in 2022. His Hulbert Ratings service tracks investment newsletters that pay a flat fee to be audited. Some elaborate market timing systems key off divergences between these two averages.

According to analysts, Humana’s stock has a predicted upside of 18.07% based on their 12-month price targets. As the healthcare industry continues to grow due to increased demand for healthcare services, now may be the perfect time to invest in fundamentally sound stocks Humana (HUM), Centene Corp (CNC), and Molina… For the full fiscal year, the company said to expect between $500 million and $506 million in revenue, a range that contains the Wall Street estimate of $501.8 million. The company expects adjusted EBITDA for the year to come in between $216 million and $222 million, while analysts anticipate $215.7 million. We are a financial media dedicated to providing stock recommendations, news, and real-time stock prices.

This Is What Whales Are Betting On Humana

In other news, two key insiders at Humana have recently sold shares in the business, raising questions about its future prospects among investors and industry analysts alike. Joseph C. Ventura and Bruce D. Broussard both made substantial sales in February, with Ventura selling 2,048 shares at an average price of $507.97 for a total value of just over $1 million and CEO Broussard selling 17,575 shares for almost $9 million. The company said to expect between $106.5 million and $107.5 million in revenue and between $39 million and $40 million in adjusted EBITDA for the first fiscal quarter. Both of those estimates were below consensus expectations, with analysts polled by FactSet anticipating revenue at $11.8 million and adjusted EBITDA at $45.4 million.

The average brokerage recommendation (ABR) for Humana (HUM) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric… Get stock recommendations, portfolio guidance, and more from The Motley Fool’s premium services. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns. An earnings beat and an encouraging piece of guidance didn’t make the share price pop. An investment in this health insurer has crushed the broader market over the past 10 years.

Please see Open to the Public Investing’s Fee Schedule to learn more. That overshadowed results from the fourth fiscal quarter. The company reported 20 cents in earnings per share excluding items, above the 17 cents expected by analysts. Revenue also beat expectations at $111 million compared with a $110.1 million forecast. Adjusted EBITDA came in at $48.9 million, ahead of the $45.7 consensus estimate.

Humana’s Q1: Strong Earnings Growth On Strength Of Medicare Advantage Business, Lifts FY23 Outlook

Humana (HUM) expects adjusted EPS to be at least $28.25 in 2023, up from the previous guidance of $28 per share. Tenet Healthcare’s (THC) first-quarter 2023 results gain on increased patient volumes. Management presently expects adjusted EPS within $4.92-$6.09 in 2023, up from the prior view of $4.68-$5.85.

The WSJ Dollar Index gained 0.2%, on pace to finish higher for the sixth session in the last eight trading days. Tech stock Keysight advanced more than 7% after the bell on the back of a strong quarterly earnings report and guidance for the current quarter. The new data was in an investor update filed with the Securities and Exchange Commission on Tuesday. Shares of Western Alliance jumped about 7% in extended trading after the bank said that its deposit growth for the current quarter surpassed $2 billion as of May 12. The pan-European Stoxx 600 index was down 0.2% at the start of the session, with most sectors and major bourses trading in negative territory.

However, Morgan Stanley boosted its target price on Humana from $620.00 to $637.00 in April and gave them an “overweight” rating, with Deutsche Bank Aktiengesellschaft also increasing its target from $562.00 to $568.00 that same month. Data are provided ‘as is’ for informational purposes only and are not intended for trading purposes. Data may be intentionally delayed pursuant to supplier requirements. You can find your newly purchased Humana stock in your portfolio—alongside the rest of your stocks, https://business-oppurtunities.com/how-to-start-your-information-technology-career-or-jumpstart-it/ ETFs, crypto, treasuries, and alternative assets. Although the revenue and EPS for Humana (HUM) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Street estimates… From a big-time patent settlement between Merck & Co. and Bristol-Myers Squibb, to Johnson & Johnson’s earnings, to Aetna and Humana’s $37 billion merger bust, we dive into the details behind last week’s biggest healthcare stories.

Humana Inc. stock underperforms Monday when compared to competitors

Upgrade to MarketBeat All Access to add more stocks to your watchlist. Humana has been rated by Cantor Fitzgerald, Deutsche Bank Aktiengesellschaft, Morgan Stanley, SVB Securities, and Truist Financial in the past 90 days. When you see Humana stock appear in the results, tap it to open up the purchase screen. There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android. Insiders who bought kr38m worth of Humana AB (publ) ( ) stock in the last year recovered part of their losses as the stock rose by 10% last week.

The 50-day moving average is a short-term technical indicator of where an asset or an index is trading. A close below that level may signal a potential change toward the downside. © 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.

The Dow led the major indexes down with a 1% drop, followed by the S&P 500 and Nasdaq Composite with respective losses of about 0.6% and 0.2%. Tuesday’s “meeting between President Biden and House Speaker McCarthy went as well as could have reasonably been hoped for,” wrote Citi chief U.S. economist Andrew Hollenhorst, in a note. “We continue to expect a long-term debt ceiling deal.” Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy.

The president also canceled the second leg of an upcoming international trip given the negotiations, the White House said. House Speaker Kevin McCarthy said that a “better process” is now in place for further talks. He also said that it’s “possible to get a deal by the end of the week.” Humana Inc. closed $48.80 below its 52-week high ($571.30), which the company reached on November 3rd.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Disappointing quarterly revenue and a lower forecast for full-year performance from Dow member Home Depot also soured investor sentiment in Tuesday’s session. On the economic front, April retail sales were weaker than anticipated by economists polled by Dow Jones.

By comparison, analysts polled by FactSet expected $1.96 per share and revenue to come in slightly lower at $1.38 billion. This bullish outlook was also supported by several other brokerages, despite some downgrades in price targets earlier this year. Stephens reduced their target from $625.00 to $590.00 and issued an “overweight” rating for Humana in February, while Cowen lowered their target from $647.00 to $581.00 and maintained an “outperform” rating on the stock that same month.

• HUM earnings call for the period ending March 31, 2021.
• The new data was in an investor update filed with the Securities and Exchange Commission on Tuesday.
• He also said that it’s “possible to get a deal by the end of the week.”
• As the healthcare industry continues to grow due to increased demand for healthcare services, now may be the perfect time to invest in fundamentally sound stocks Humana (HUM), Centene Corp (CNC), and Molina…
• Alternative Assets.Brokerage services for alternative assets available on Public are offered by Dalmore Group, LLC (“Dalmore”), member of FINRA & SIPC.

The Company offers coordinated health insurance coverage and related services through a variety of traditional and consumer-choice plans for government-sponsored programs, employer groups, and individuals. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Their rationale is that the transportation sector is a good leading indicator of the stock market. And this rationale does seem plausible, since transportation stocks, especially those of freight transportation companies, should be among the first to weaken when the economy begins to lose steam — earlier even than industrial stocks.

None of this means there is no significance to the current divergence between the Dow transports and the Dow industrials. The correct conclusion is that neither Dow average, by itself, is a good leading indicator of the overall market. I found that neither Dow average was a consistently good leading indicator. In some decades, one or other of the Dow averages was positively correlated with the S&P 500’s subsequent return, and in other decades one or both were inversely correlated. The net result was that no correlation over the entire period met traditional standards of statistical significance.

Stock futures are ticking higher, suggesting major indexes could recover slightly after falling Tuesday on worries about a potential debt-ceiling default. Meanwhile, regional bank shares are jumping, on track to extend a recent stretch of high volatility. Western Alliance shares have been on a recent upswing, up 17% over the past week – and posting a gain of 15% since this week has begun. The stock is still down nearly 47% for the year, however. “While McCarthy said a deal is possible by end of this week, the timeline may be by the end of next week ahead of the Memorial Day,” JPMorgan traders wrote. “With that in mind, Equities may trade in a tight range until an outcome is observed with the biggest downside risk coming if we enter Memorial Day weekend without a solution, given the early June x-date.”

Financial services made the biggest losses, down 1.3%, followed by autos, which dropped 0.9%. Health care modestly bucked the trend with a 0.1% uptick. Traders at JPMorgan expect the market to remain in a tight trading range as lawmakers try to reach a deal on the U.S. debt ceiling. Concerns over the potential of default weighed on investors in Tuesday’s regular session.

• Though the specific rules of how to apply the Dow Theory are beyond the scope of this column, I note that Dow theorists interpret the rules differently.
• Tuesday’s “meeting between President Biden and House Speaker McCarthy went as well as could have reasonably been hoped for,” wrote Citi chief U.S. economist Andrew Hollenhorst, in a note.
• However, Morgan Stanley boosted its target price on Humana from $620.00 to $637.00 in April and gave them an “overweight” rating, with Deutsche Bank Aktiengesellschaft also increasing its target from $562.00 to $568.00 that same month.
• Revenue also beat expectations at $111 million compared with a $110.1 million forecast.

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction. HUM earnings call for the period ending December 31, 2020. HUM earnings call for the period ending March 31, 2021.

After each calculation the program assigns a Buy, Sell, or Hold value with the study, depending on where the price lies in reference to the common interpretation of the study. For example, a price above its moving average is generally considered an upward trend or a buy. Target traded more than 2% lower in the premarket after the retailer reported total revenue of $25.32 billion for the first quarter, which represented year-over-year growth of just 1%. To be sure, that revenue figure, along with the company’s earnings per share, exceeded analyst expectations. In its fiscal second quarter, the company reported $2.12 in earnings per share without items and $1.39 billion in revenue.

Stock futures rose Wednesday as investors awaited news of developments in the negotiations between congressional leaders and President Joe Biden on the U.S. debt ceiling. The accompanying chart illustrates this market history. As you can see, both Dow averages tend to rise and fall in fairly close lockstep with the S&P 500. PacWest Bancorp and and Western Alliance Bancorp led gains, while others such as Comerica and Zions Bancorporation also rose.

Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings, Inc. (“Public Holdings”). This is not an offer, solicitation of an offer, or advice to buy or sell securities or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered.

The issuers of these securities may be an affiliate of Public, and Public (or an affiliate) may earn fees when you purchase or sell Alternative Assets. No offer to buy securities can be accepted, and no part of the purchase price can be received, until an offering statement filed with the SEC has been qualified by the SEC. Any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of acceptance given after the date of qualification by the SEC or as stated in the offering materials relating to an investment opportunity, as applicable. An indication of interest to purchase securities involves no obligation or commitment of any kind.